This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kato, T. Articles by Granger, J. P. Search for Related Content PubMed PubMed Citation Articles by Kato, T. Articles by Granger, J. P.

(Hypertension. 1995;25:883-887.)
© 1995 American Heart Association, Inc.

Articles

Endothelin Antagonists Improve Renal Function in Spontaneously Hypertensive Rats

Tatsuya Kato; Salah Kassab; Fred C. Wilkins, Jr; Kent A. Kirchner; Joan Keiser; Joey P. Granger

From the Department of Physiology and Biophysics, Division of Nephrology, University of Mississippi Medical Center, Jackson, and Parke-Davis, Ann Arbor, Mich.

Correspondence to Joey P. Granger, PhD, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N State Street, Jackson, MS 39216-4505.

Abstract Hypertension in the spontaneously hypertensive rat (SHR) is associated with reduced renal excretory function, low renal plasma flow, reduced glomerular filtration rate, and reduced renal interstitial hydrostatic pressure. The mechanisms responsible for these abnormalities in renal function are unknown. The purpose of this study was to determine the role of intrarenal endothelin in altering renal hemodynamic and excretory function in the SHR. Both PD 145065 (an endothelin A and B receptor antagonist) and FR 139317 (a selective endothelin A receptor antagonist) or saline was infused into the renal interstitium of 14- to 16-week-old SHR (n=7) and age-matched Wistar-Kyoto rats (WKY) (n=7). Renal perfusion pressure in some SHR was reduced to that of the WKY by a servocontrol system. At a renal perfusion pressure of 124±4 mm Hg, infusion of PD 145065 (0.03 mg · kg^-1 · min^-1) and FR 139317 (0.02 mg · kg^-1 · min^-1) significantly increased glomerular filtration rate (22%), renal plasma flow (37%), and renal interstitial hydrostatic pressure (from 3.2±0.5 to 5.4±0.6 mm Hg) in the SHR. These changes were associated with significant increases in urine flow, absolute sodium excretion, and fractional excretion of sodium. Similar improvements in renal plasma flow, renal interstitial hydrostatic pressure, and renal excretory function were obtained in the SHR whose renal perfusion pressure was not reduced (n=7). Renal interstitial infusion of endothelin receptor antagonists had no effect on renal hemodynamic or excretory function in the WKY. These data demonstrate that endothelin receptor blockade within the kidney improves renal hemodynamic and excretory function in the SHR. These results suggest that intrarenal endothelin may mediate, in part, the abnormal renal function in the SHR.

Key Words: hydrostatic pressure • natriuresis • renal circulation

This article has been cited by other articles:

				J. L. Garvin and M. Herrera Physiological actions of renal collecting duct endothelin Am J Physiol Renal Physiol, May 1, 2005; 288(5): F910 - F911. [Full Text] [PDF]

				M. H. Sedeek, M. T. Llinas, H. Drummond, L. Fortepiani, S. R. Abram, B. T. Alexander, J. F. Reckelhoff, and J. P. Granger Role of Reactive Oxygen Species in Endothelin-Induced Hypertension Hypertension, October 1, 2003; 42(4): 806 - 810. [Abstract] [Full Text] [PDF]

				R. Yang, A. K. Ogasawara, T. F. Zioncheck, Z. Ren, G.-W. He, G. G. DeGuzman, N. Pelletier, B.-Q. Shen, S. Bunting, and H. Jin Exaggerated Hypotensive Effect of Vascular Endothelial Growth Factor in Spontaneously Hypertensive Rats Hypertension, March 1, 2002; 39(3): 815 - 820. [Abstract] [Full Text] [PDF]

				E. L. Schiffrin Role of Endothelin-1 in Hypertension Hypertension, October 1, 1999; 34(4): 876 - 881. [Abstract] [Full Text] [PDF]

				T. Disashi, H. Nonoguchi, T. Iwaoka, S. Naomi, Y. Nakayama, K. Shimada, K. Tanzawa, and K. Tomita Endothelin Converting Enzyme-1 Gene Expression in the Kidney of Spontaneously Hypertensive Rats Hypertension, December 1, 1997; 30(6): 1591 - 1597. [Abstract] [Full Text]

				P. Nambi, M. Pullen, J. Kincaid, P. Nuthulaganti, N. Aiyar, D. P. Brooks, M. Gellai, and C. Kumar Identification and Characterization of a Novel Endothelin Receptor That Binds Both ETA- and ETB-Selective Ligands Mol. Pharmacol., October 1, 1997; 52(4): 582 - 589. [Abstract] [Full Text]

				P. J. Wookey, Z. Cao, R. C.I. van Geenen, M. Voskuil, I. A. Darby, R. Komers, and M. E. Cooper Increased Density of Renal Amylin Binding Sites in Experimental Hypertension Hypertension, September 1, 1997; 30(3): 455 - 460. [Abstract] [Full Text]

				K. Skov, J. Fenger-Gron, and M. J. Mulvany Effects of an Angiotensin-Converting Enzyme Inhibitor, a Calcium Antagonist, and an Endothelin Receptor Antagonist on Renal Afferent Arteriolar Structure Hypertension, September 1, 1996; 28(3): 464 - 471. [Abstract] [Full Text]